Hypoplastic Left Heart Syndrome with Mitral Stenosis and Aortic Atresia – Echocardiographic Findings and Early Outcomes
Hunter C Wilson,Vikram Sood,Jennifer C Romano,Jeffrey D Zampi,Jimmy C Lu,Sunkyung Yu,Ray E Lowery,Kellianne Kleeman,Sowmya Balasubramanian,Hunter C. Wilson,Jennifer C. Romano,Jeffrey D. Zampi,Jimmy C. Lu,Ray E. Lowery
DOI: https://doi.org/10.1016/j.echo.2024.02.008
IF: 7.722
2024-03-03
Journal of the American Society of Echocardiography
Abstract:Highlights • Literature is mixed on risk conferred by sinusoids in hypoplastic left heart syndrome • We find no association of sinusoids or other imaging variables with adverse outcome • We identify several clinical factors associated with adverse outcome • Presence of sinusoids alone should not preclude stage I palliation Background Mitral stenosis/aortic atresia (MS/AA) has been reported as a high-risk variant of hypoplastic left heart syndrome (HLHS), potentially related to ventriculocoronary connections (VCCs) or endocardial fibroelastosis (EFE) and myocardial hypoperfusion. We aimed to identify echocardiographic and clinical factors associated with early death or transplant in this group. Methods Patients with HLHS MS/AA treated at our center between 2000 and 2020 were included. Pre stage I palliation echocardiograms were reviewed. Certain imaging factors, such as determination of VCC, EFE, and measurement of tricuspid annular plane systolic excursion (TAPSE) were measures from retrospective review of pre-operative images; others were derived from clinical reports. Groups were compared according to primary outcome of death or transplant prior to stage II palliation (S2P). Results Of 141 patients included, 39 (27.7%) experienced primary outcome. VCCs were identified in 103 (73.0%) patients and EFE in 95 (67.4%) patients. Among imaging variables, smaller ascending aorta size (median 2.2 [IQR 1.7-2.8] vs 2.6 [2.2-3.4] mm, p=0.01) was associated with primary outcome. There was similar frequency of VCC (74.4 vs 72.5%, p=0.83), EFE (59.0 vs 72.5%, p=0.19), moderate or greater tricuspid regurgitation (5.1 vs 5.9%, p=1.00), and similar right ventricular systolic function (indexed TAPSE 32.5 ± 7.3 vs 31.4 ± 7.2 mm/m 2 , p=0.47) in the primary outcome group compared to other patients. Clinical factors associated with primary outcome included lower birth weight (mean 2.8 ± SD 0.8 vs 3.3 ± 0.5 kg, p=0.0003), gestational age <37 weeks (31.6 vs 4.9%, p<.0001), longer cardiopulmonary bypass time (median 112 [IQR 93-162] vs 82 [71-119] minutes, p=0.001), longer intensive care unit length of stay (median 19 [IQR 10-30] vs 10 [7-15] days, p=0.001), and extracorporeal membrane oxygenation following stage I palliation (43.6 vs 8.8%, p<.0001). Presence of VCCs and EFE were not associated with death or transplant after controlling for birth weight and era of S1P. Conclusions In one of the largest reported single-center cohorts of HLHS MS/AA, there were few pre-stage I palliation imaging characteristics associated with primary outcome. Imaging findings evaluated in this study, including the presence of VCC and/or EFE as determined using highly sensitive echocardiogram criteria, should not preclude intervention, although impact on long-term outcomes requires further evaluation.
cardiac & cardiovascular systems